Status:
COMPLETED
No Reflow Phenomenon Incidence and Predictors
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Conditions:
No Reflow Phenomenon
STEMI
Eligibility:
All Genders
18+ years
Brief Summary
Background No reflow phenomenon is described in up to 65% of patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction (STEMI). It is known to be associated...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Presenting with ST elevation myocardial infarction
- Appropriate for Primary Percutaneous Coronary Intervention
Exclusion
- Primary Percutaneous Coronary Intervention not performed eg due to non- flow- limiting coronary artery disease
- Unsuccessful PCI
- Thrombolysis
- Patients who do not survive the procedure to leave the catheterisation laboratory
Key Trial Info
Start Date :
October 29 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT04017169
Start Date
October 29 2015
End Date
September 1 2017
Last Update
July 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Castle Hill Hospital (Hull and east Yorkshire Hospitals NHS Trust)
Cottingham, East Yorkshire, United Kingdom, HU16 5JQ